Open Insider Trading Activity for Crispr Therapeutics Ag Chief Medical Officer Patel Naimish
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CRSP | 2026-06-01 | 2026-05-29 | Crispr Therapeutics Ag | Patel Naimish | Chief Medical Officer | Sell | 1 | 3,786 | $55.62 | $210,577.32 | 16.36% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CRSP | 2026-03-17 | 2026-03-16 | Crispr Therapeutics Ag | Patel Naimish | Chief Medical Officer | Sell | 1 | 3,150 | $48.26 | $152,019.00 | 19.33% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CRSP | 2026-01-27 | 2025-04-03 | Crispr Therapeutics Ag | Patel Naimish | Chief Medical Officer | Buy | 1 | 1,508 | $32.96 | $49,703.68 | 100.00% | View Filing |